| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.49 | 0.002 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.099 | 0.002 |